Skip to main content
CANN GROUP LIMITED logo

CANN GROUP LIMITED — Investor Relations & Filings

Ticker · CAN ISIN · AU000000CAN2 LEI · 529900XX42XELLXVQE42 ASX Manufacturing
Open in API
Filings indexed 729 across all filing types
Latest filing 2023-01-31 Share Issue/Capital Cha…
Country AU Australia
Listing ASX CAN

About CANN GROUP LIMITED

https://www.canngrouplimited.com/

Cann Group Limited specializes in the cultivation, manufacture, and supply of medicinal cannabis products. The company focuses on providing pharmaceutical-grade cannabis for therapeutic use, utilizing advanced greenhouse technology and automated cultivation systems to ensure standardized quality and consistency. Its operations encompass the entire supply chain, from plant genetics and breeding to the production of finished medicinal products, including oils and dried flower. Cann Group serves healthcare professionals and patients through established distribution channels and maintains a focus on research and development to advance cannabinoid-based treatments. The company leverages large-scale production capabilities to meet growing demand in both domestic and international medicinal markets, emphasizing rigorous quality control and compliance with international pharmaceutical standards.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - CAN 6 pages 27.9KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities previously issued under an employee incentive scheme where transfer restrictions have ceased. It details the number of securities to be quoted, issue dates, and confirms that these securities will rank equally with existing securities. The document is an announcement related to capital changes, specifically the quotation of shares following the lifting of transfer restrictions on employee incentive shares. There are no financial statements or performance data, nor is it a report or presentation. This fits the category of Share Issue/Capital Change announcements.
2023-01-31 English
Quarterly Activities and Appendix 4C Cashflow Report 9 pages 415.7KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 30 January 2023, titled "December 2022 Quarterly Activities Report and Appendix 4C." It contains detailed financial data for the quarter ended 31 December 2022, including cash flow statements, operating activities, investing and financing activities, and sales and production updates. It also includes operational highlights, share purchase plan details, R&D updates, and board and management changes. The presence of the Appendix 4C quarterly cash flow report, which is a regulatory requirement for Australian listed entities, confirms this is a quarterly report with substantive financial data and analysis. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q2 2023
2023-01-29 English
S3 Trial update 1 page 126.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 19 January 2023, providing preliminary results from a Phase 3 clinical trial conducted by Cann Group. It discusses trial design, preliminary efficacy results, and expected delays in regulatory submission. The content is a clinical trial update and market communication rather than a financial report, regulatory filing, or management discussion. It does not contain financial statements, voting results, or executive changes. The document is relatively short (2209 characters) and serves as a market update announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-01-18 English
Appointment of new CEO 3 pages 198.8KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 10 January 2023 regarding the appointment of a new CEO, Peter Koetsier, at Cann Group Limited. It details the executive's background, remuneration, incentive plans, options grant, and termination notice. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content focuses solely on management change and executive appointment details. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 6597 characters, which is sufficient for a detailed announcement but does not constitute a full report or financial filing.
2023-01-09 English
Cann Group agrees terms for the sale of Southern facility 2 pages 179.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 23 December 2022 regarding the sale of Cann Group's Southern Facility. It details terms of the sale, including land and business assets, contract manufacturing arrangements, and access to genetics. The content focuses on a transaction and operational update rather than financial results, regulatory certifications, or management changes. There is no indication of it being a full financial report, audit, or earnings release. The document is a formal announcement of a capital transaction and operational restructuring. Therefore, it fits best under Capital/Financing Update (CAP). The document length (6180 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2022-12-22 English
Application for quotation of securities - CAN 6 pages 27.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX by Cann Group Limited. It details the number and type of securities to be quoted, issue dates, and issued capital following quotation. It references previous announcements and Appendix 3B filings related to securities issuance. The content is focused on the listing and quotation of new securities rather than financial results, management changes, or other report types. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues and capital changes.
2022-12-06 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.